VTVT vTv Therapeutics Forecast, Technical & Fundamental Analysis

a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

VTVT is expected to report earnings to fall 12.50% to -7 cents per share on February 28

vTv Therapeutics VTVT Stock Earnings Reports

Q4'23

Est.

$-0.07

Q3'23

Est.

$-0.08

Q2'23

Missed

by $2.73

Q1'23

Beat

by $0.05

Q4'22

Missed

by $2.34

The last earnings report on November 09 showed earnings per share of -7 cents, meeting the estimate of -7 cents. With 22.77K shares outstanding, the current market capitalization sits at 51.22M.

A.I. Advisor

published General Information

General Information

a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3980 Premier Drive

Phone

+1 336 841-0300

Employees

Web

https://www.vtvtherapeutics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GNTY	33.58	1.52	+4.74%
Guaranty Bancshares
LTRN	4.57	0.15	+3.39%
Lantern Pharma
GLBE	34.49	0.42	+1.23%
Global-E Online Ltd
FDX	298.59	0.31	+0.10%
FedEx Corp
KN	18.31	-0.07	-0.38%
KNOWLES Corp

VTVT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTVT has been loosely correlated with VANI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VTVT jumps, then VANI could also see price increases.

Ticker / NAME	Correlation To VTVT	1D Price Change %
VTVT	100%	-11.35%
VANI - VTVT	54% Loosely correlated	+1.63%
MACK - VTVT	29% Poorly correlated	N/A
TRAW - VTVT	25% Poorly correlated	-3.91%
ADIL - VTVT	25% Poorly correlated	-0.84%
AUPH - VTVT	24% Poorly correlated	+0.72%
More